Mar 2, 2026 08:00AM
Feb 26, 2026 07:30AM
Nov 12, 2025 08:00AM
Nov 6, 2025 07:30AM
May 19, 2025 04:01PM
May 12, 2025 08:05AM
May 12, 2025 08:05AM Collegium Announces $25 Million Accelerated Share Repurchase Program
May 8, 2025 04:01PM
Mar 4, 2025 08:00AM
Nov 12, 2024 08:00AM
Nov 11, 2024 03:55PM
Jun 7, 2024 03:04AM
May 29, 2024 08:00AM
May 13, 2024 08:03AM Collegium Pharma (COLL) Announces $35M Accelerated Share Buyback
May 13, 2024 08:00AM
Jan 4, 2024 05:03AM
Nov 9, 2023 08:00AM
Nov 9, 2023 08:00AM
Nov 8, 2023 08:00AM
Aug 7, 2023 07:30AM
Aug 7, 2023 07:30AM Collegium Announces $50 Million Accelerated Share Repurchase Program
Jun 1, 2023 08:00AM
May 2, 2023 08:55AM
Feb 14, 2022 06:30AM
Feb 14, 2022 06:30AM
Feb 14, 2022 06:30AM
Feb 14, 2022 06:30AM
Feb 14, 2022 06:30AM Collegium to Acquire BioDelivery Sciences Broadening Pain Portfolio
Nov 15, 2021 08:39AM
Nov 15, 2021 08:34AM
Nov 15, 2021 08:30AM
Nov 15, 2021 08:30AM
Nov 11, 2021 04:54PM
Nov 11, 2021 04:54PM
Nov 11, 2021 04:01PM Collegium Participate in Upcoming Conferences
Nov 11, 2021 04:01PM
May 20, 2021 04:05PM
May 20, 2021 04:05PM
Jan 7, 2021 08:24AM
Feb 13, 2020 04:01PM
Feb 13, 2020 04:01PM
Feb 10, 2020 07:15PM Collegium Pharmaceutical, Inc. Prices $125.0 Million Convertible Senior Notes Offering
Feb 10, 2020 07:14PM
Feb 10, 2020 07:21AM
Feb 10, 2020 07:20AM
Feb 10, 2020 07:20AM
Feb 6, 2020 05:07PM
Feb 6, 2020 04:01PM
Feb 6, 2020 04:01PM Collegium to Acquire U.S. Rights to Nucynta Franchise
Feb 6, 2020 04:01PM

69,742 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All